Martin Smith
Executive Vice President of Global Operations and R&DDr. Martin Smith is Executive Vice President of Global Operations and R&D of IDEXX Laboratories, Inc. since January 2025. Dr. Smith was Executive VP & CTO of IDEXX Laboratories, Inc. from August 16, 2021 to January 2025. Prior to joining IDEXX, he served as Vice President and Chief Technology Officer of Cytiva, which is part of Danaher Corporation, from August 2020 to July 2021. Previously, Dr. Smith has held various leadership positions with increasing responsibilities at Pall Corporation. He served as Chief Technology Officer of Pall Corporation. Prior roles at Pall included Senior Vice President, Pall R&D from 2010 to 2014, Vice President, Research & Development, Pall Medical from 2008 to 2010 and Senior Director, Pall Life Science R&D from 2006 to 2008. Dr. Smith received a bachelor’s degree in biological sciences from University of Essex, a master’s degree in biotechnology from Reading University and a Ph.D. in Cell Biology from University College London. He is the holder of multiple U.S. issued patents in the area of separations science.
Positions
- Company NameIDEXX Laboratories, Inc.Stock CodeIDXXPositionExecutive Vice President of Global Operations and R&DColleagues
- JJJonathan J. MazelskyExecutive Chairman
- AEAndrew EmersonExecutive VP, CFO & Treasurer
- MJMichael J. LaneExecutive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology
- MGMichael G. EricksonCEO, President & Director
- SMStuart M. EssigIndependent Director
- SASam A. SamadIndependent Director
- ICIrene Chang BrittIndependent Director
